NIH shares data on Alzheimer's biomarkers

The NIH is sharing data from a proteomics study launched to identify new plasma-based biomarkers for Alzheimer's disease. The study, the first in a multi-phase program, was undertaken by a team of experts drawn from academia, industry and the government. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.